Akebia Therapeutics, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 56.2 million compared to USD 55.78 million a year ago. Net income was USD 0.613 million compared to net loss of USD 6.07 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.225 USD | -7.89% | -10.95% | -1.61% |
05-09 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.61% | 278M | |
+3.74% | 108B | |
+11.17% | 104B | |
+1.28% | 22.33B | |
-12.72% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.47% | 17.64B | |
+3.77% | 14.05B | |
+37.52% | 12.51B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Akebia Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023